In many types of cancers, PD-1 is highly expressed in tumour-infiltrating lymphocytes (TILs), including both CD4+ and CD8+ T cells, and the upregulated protein expression is correlated with tumour size and worse overall survival of cancer patients [11,12]. The gene discussed is CD4; the disease is neoplasm.